nach oben

Erschienen in:

01.06.2019 | Case report

Erythromycin

GI side effects: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A 38-year-old woman developed GI side effects during treatment with erythromycin for prurigo pigmentosa. The woman presented with an 8-year history of reticulate hyperpigmentation involving her trunk and neck in September 2016. A clinical diagnosis of prurigo pigmentosa was made, and she started receiving oral erythromycin [dosage and route not stated]. She developed GI side effects on erythromycin treatment [duration of treatment to reaction inset not stated] leading to its discontinuation. Her therapy was transitioned to topical betamethasone dipropionate and tacrolimus [outcome not stated]. …

Ross A, et al. Prurigo pigmentosa - Response to treatment with Q-Switched neodymium: YAG at 532 nm. Australasian Journal of Dermatology 60: 147-149, No. 2, May 2019. Available from: URL: http://doi.org/10.1111/ajd.12943 - Australia

Titel: Erythromycin
GI side effects: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63715-5

Springer Medizin

Erythromycin

GI side effects: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Tocilizumab

Sevoflurane

Lamivudine

Ketorolac

Aspirin/azilsartan/vildagliptin/metformin

Methotrexate

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Tocilizumab

Sevoflurane

Lamivudine

Ketorolac

Aspirin/azilsartan/vildagliptin/metformin

Methotrexate